Rifaximin for the treatment of irritable bowel syndrome

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.13, Iss.3, 2012-02, pp. : 433-440

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Rifaximin: The Revolutionary Antibiotic Approach for Irritable Bowel Syndrome

Mini Reviews in Medicinal Chemistry, Vol. 16, Iss. 3, 2016-02 ,pp. : 186-192

Bentham Science Publishers

Access to resources Recommend Favorite

Asimadoline in the treatment of irritable bowel syndrome

By Mangel Allen W Williams Valerie SL

Expert Opinion on Investigational Drugs, Vol. 19, Iss. 10, 2010-10 ,pp. : 1257-1264

Informa Healthcare

Access to resources Recommend Favorite

Treatment Options for Irritable Bowel Syndrome Set to Increase

Pharmaceutical & Diagnostic Innovation, Vol. 2, Iss. 1, 2004-05 ,pp. : 12-17

Adis International

Access to resources Recommend Favorite

Review of tegaserod in the treatment of irritable bowel syndrome

By Patel Sonal Berrada Driss Lembo Anthony

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 11, 2004-11 ,pp. : 2369-2379

Informa Healthcare

Access to resources Recommend Favorite

Probiotic Agents in the Treatment of Irritable Bowel Syndrome

By Guslandi M

The Journal of International Medical Research, Vol. 35, Iss. 5, 2007-09 ,pp. : 583-589

Field House Publishing

Access to resources Recommend Favorite